Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in Aneurysmal Subarachnoid Hemorrhage
NCT05664191Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2023
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levosimendan in subarachnoid hemorrhage (SAH), sponsored by Assistance publique - Hôpitaux de Paris. Started Oct 2023; status: completed.
02
Drugs
levosimendan
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT05664191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05664191.